CordenPharma International

CordenPharma International products

A

• APIs (Active Pharmaceutical Ingredients)
  Capability to develop and manufacture peptides, oligonucleotides, small molecules, and highly potent oncology-grade APIs, supported by technologies like flow chemistry, purification, crystallization, and TAPS (Tag-Assisted Peptide Synthesis).

B

• Bioavailability Enhancement
  Specialized technologies such as spray drying, hot-melt extrusion, nanomilling, and lipid-based systems to enhance solubility of challenging APIs.

D

• Drug Products (Non-Sterile & Sterile)
  Non-sterile forms: Oral solid dose (tablets, capsules), liquids (suspensions, sprays), rectal forms (suppositories, enemas).
  Sterile forms: Injectable solutions, emulsions, lyophilized powders, in vials, ampoules, pre-filled syringes—all under aseptic or terminal sterilization.

H

• Highly Potent & Oncology Solutions
  End-to-end development and manufacturing of oncology APIs, oral solid doses, and injectables with containment systems for extremely potent compounds (down to picogram levels).

L

• Lipid Excipients & LNPs (Lipid Nanoparticles)
  Comprehensive catalog of standard and custom lipids (e.g., phospholipids, PEGylated lipids, plant-based cholesterol) ranging from research-grade to commercial-scale, including LNP starter kits and GMP-scale LNP formulation and manufacturing capabilities.

P

• Packaging & Serialization Services
  Full-spectrum packaging including primary (bottles, blisters, syringes) and secondary (labeling, serialization) solutions compliant with regulatory requirements across supply chain scales.

S

• Sterile Injectables & Lyophilized Products
  GMP-grade formulation and fill-finish of sterile injectables, including emulsions and lyophilized powders, across clinical to commercial scales.